Cryolife Stock Current Valuation
Valuation analysis of CryoLife helps investors to measure CryoLife's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
CryoLife Company Current Valuation Analysis
CryoLife's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CryoLife Current Valuation | 1.07 B |
Most of CryoLife's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CryoLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, CryoLife has a Current Valuation of 1.07 B. This is 92.55% lower than that of the Healthcare sector and 91.39% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 93.56% higher than that of the company.
CryoLife Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CryoLife's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CryoLife could also be used in its relative valuation, which is a method of valuing CryoLife by comparing valuation metrics of similar companies.CryoLife is currently under evaluation in current valuation category among its peers.
CryoLife Fundamentals
| Return On Equity | 0.57 | |||
| Return On Asset | 1.01 | |||
| Profit Margin | 0.63 % | |||
| Operating Margin | 12.82 % | |||
| Current Valuation | 1.07 B | |||
| Shares Outstanding | 39.33 M | |||
| Shares Owned By Insiders | 3.70 % | |||
| Shares Owned By Institutions | 83.78 % | |||
| Number Of Shares Shorted | 3.47 M | |||
| Price To Earning | 425.71 X | |||
| Price To Book | 2.26 X | |||
| Price To Sales | 2.45 X | |||
| Revenue | 287.34 M | |||
| Gross Profit | 167.78 M | |||
| EBITDA | 36.84 M | |||
| Net Income | 1.79 M | |||
| Cash And Equivalents | 64.59 M | |||
| Cash Per Share | 1.64 X | |||
| Total Debt | 363.37 M | |||
| Debt To Equity | 1.17 % | |||
| Current Ratio | 4.21 X | |||
| Book Value Per Share | 7.92 X | |||
| Cash Flow From Operations | 2.15 M | |||
| Short Ratio | 15.98 X | |||
| Earnings Per Share | 0.04 X | |||
| Price To Earnings To Growth | 508.75 X | |||
| Number Of Employees | 1.2 K | |||
| Beta | 1.53 | |||
| Market Capitalization | 703.21 M | |||
| Total Asset | 181.18 M | |||
| Retained Earnings | 29.43 M | |||
| Working Capital | 90.06 M | |||
| Current Asset | 109.66 M | |||
| Current Liabilities | 19.61 M | |||
| Z Score | 1.6 | |||
| Last Dividend Paid | 0.03 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in CryoLife Stock
If you are still planning to invest in CryoLife check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CryoLife's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |